Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04454216 · ClinicalTrials.gov registry record

GSD VI and GSD IX Natural History

A clinical trial of Glycogen Storage Disease VI and GLYCOGEN STORAGE DISEASE IXa1, sponsored by Duke University.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT04454216 is a study of Glycogen Storage Disease VI and GLYCOGEN STORAGE DISEASE IXa1 that is actively recruiting participants, run by Duke University. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04454216, a study of Glycogen Storage Disease VI and GLYCOGEN STORAGE DISEASE IXa1, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

Collection and review of clinical information related to Glycogen Storage Disease Type VI (GSD VI) OR Glycogen Storage Disease Type IX (GSD IX) generated during clinic visits.

Interventions

  • OTHER No intervention

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-09-18
Est. Completion 2030-01-01

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04454216

The ClinicalTrials.gov registry entry for NCT04454216 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Glycogen Storage Disease VI appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT04454216 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04454216 about?

NCT04454216 is a clinical study titled "GSD VI and GSD IX Natural History". Collection and review of clinical information related to Glycogen Storage Disease Type VI (GSD VI) OR Glycogen Storage Disease Type IX (GSD IX) generated during clinic visits.

What is the current status of trial NCT04454216?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-09-18. Estimated completion is 2030-01-01.

What conditions does trial NCT04454216 study?

This clinical trial studies the following conditions: Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2, Glycogen Storage Disease IXB, Glycogen Storage Disease IXC.

What interventions are being tested in trial NCT04454216?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT04454216?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04454216 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.